Clinical Trial Update: Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride [Phase 4]

View source ↗

Summary

Phase 4 study comparing rosiglitazone to placebo evaluated cardiovascular performance and myocardial triglyceride levels in adults with Type 2 diabetes; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (Avandia) (rosiglitazone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2012-03-30